Metoprolol Succinate Extended-Release Tablets — Class II drug recall D-0451-2022
Terminated recall by American Health Packaging, reported 2022-02-02, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-0451-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | American Health Packaging, Columbus, OH, United States |
| Recall initiated | 2021-12-20 |
| Classified | 2022-01-25 |
| Reported by FDA | 2022-02-02 |
| Terminated | 2023-03-09 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 68001-0500, 68001-0500-00, 68001-0500-03, 68001-0500-08, 68001-0501, 68001-0501-00, 68001-0501-03, 68001-0501-08, 68001-0502, 68001-0502-00, 68001-0502-03, 68001-0502-08, 68001-0503, 68001-0503-00 |
| Lot numbers | 21141983, 21141984, 21141985, 21142017, 21142018, 21142019 |
| Expiration dates | 2023-02-28, 2023-03-31 |
Product
Metoprolol Succinate Extended-Release Tablets, USP 50 mg, 500-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., Mumbai - 400 013 INDIA. NDC 68001-501-03
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0451-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.